p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches
- PMID: 7600570
- DOI: 10.1016/s0092-8674(05)80006-6
p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches
Abstract
Insertion/deletion (IDL) mismatches in DNA are lesions consisting of extra bases on one strand. Here, the binding of p53 and its 14 kDa C-terminal domain to DNAs containing one or three 3-cytosine IDL mismatches was examined. Electron microscopy showed that both p53 forms bound predominantly as tetramers at the lesions while single-stranded binding proteins did not bind. Gel retardation assays showed that p53 formed highly stable complexes when the DNA contained the IDL mismatches, but only unstable complexes when the DNA lacked lesions (but did contain free ends). The highly stable complexes had a half-life of > 2 hr, suggesting that upon encountering lesions, p53 may recruit other proteins to the site, providing a signal for DNA damage.
Similar articles
-
The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.Nucleic Acids Res. 1996 Sep 15;24(18):3560-7. doi: 10.1093/nar/24.18.3560. Nucleic Acids Res. 1996. PMID: 8836183 Free PMC article.
-
High affinity insertion/deletion lesion binding by p53. Evidence for a role of the p53 central domain.J Biol Chem. 1999 Feb 5;274(6):3904-9. doi: 10.1074/jbc.274.6.3904. J Biol Chem. 1999. PMID: 9920946
-
p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core.Nucleic Acids Res. 2000 Oct 15;28(20):4005-12. doi: 10.1093/nar/28.20.4005. Nucleic Acids Res. 2000. PMID: 11024181 Free PMC article.
-
Analysis of the binding of p53 to DNAs containing mismatched and bulged bases.J Biol Chem. 2001 Mar 23;276(12):8778-84. doi: 10.1074/jbc.M006795200. Epub 2000 Dec 20. J Biol Chem. 2001. PMID: 11124254
-
Proteolytic cleavage of p53: a model for the activation of p53 in response to DNA damage.Oncol Res. 1997;9(6-7):267-73. Oncol Res. 1997. PMID: 9406231 Review.
Cited by
-
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.Cell Death Dis. 2024 Jun 12;15(6):412. doi: 10.1038/s41419-024-06783-7. Cell Death Dis. 2024. PMID: 38866752 Free PMC article. Review.
-
The levels of p53 govern the hierarchy of DNA damage tolerance pathway usage.Nucleic Acids Res. 2024 Apr 24;52(7):3740-3760. doi: 10.1093/nar/gkae061. Nucleic Acids Res. 2024. PMID: 38321962 Free PMC article.
-
TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.Cancer Med. 2023 Jun;12(11):12438-12451. doi: 10.1002/cam4.5953. Epub 2023 Apr 20. Cancer Med. 2023. PMID: 37081749 Free PMC article.
-
p53: From Fundamental Biology to Clinical Applications in Cancer.Biology (Basel). 2022 Sep 6;11(9):1325. doi: 10.3390/biology11091325. Biology (Basel). 2022. PMID: 36138802 Free PMC article. Review.
-
Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity.Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2113233119. doi: 10.1073/pnas.2113233119. Epub 2022 Mar 2. Proc Natl Acad Sci U S A. 2022. PMID: 35235448 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
